107 related articles for article (PubMed ID: 8566809)
1. Monovalent phage display of human interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in the hIL-6 D-helix.
Cabibbo A; Sporeno E; Toniatti C; Altamura S; Savino R; Paonessa G; Ciliberto G
Gene; 1995 Dec; 167(1-2):41-7. PubMed ID: 8566809
[TBL] [Abstract][Full Text] [Related]
2. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
[TBL] [Abstract][Full Text] [Related]
3. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.
Aoki Y; Narazaki M; Kishimoto T; Tosato G
Blood; 2001 Nov; 98(10):3042-9. PubMed ID: 11698289
[TBL] [Abstract][Full Text] [Related]
4. Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.
Li H; Nicholas J
J Virol; 2002 Jun; 76(11):5627-36. PubMed ID: 11991991
[TBL] [Abstract][Full Text] [Related]
5. Phage presentation and affinity selection of a deletion mutant of human interleukin-3.
Merlin S; Rowold E; Abegg A; Berglund C; Klover J; Staten N; McKearn JP; Lee SC
Appl Biochem Biotechnol; 1997 Sep; 67(3):199-214. PubMed ID: 9332969
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies.
Kalai M; Montero-Julian FA; Brakenhoff JP; Fontaine V; De Wit L; Wollmer A; Brailly H; Content J; Grötzinger J
Eur J Biochem; 1997 Nov; 249(3):690-700. PubMed ID: 9395315
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6.
Chen D; Nicholas J
J Virol; 2006 Oct; 80(19):9811-21. PubMed ID: 16973585
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R
Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391
[TBL] [Abstract][Full Text] [Related]
9. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P; Persson E; Conaway HH; Lerner UH
J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction.
Kalai M; Montero-Julian FA; Grötzinger J; Fontaine V; Vandenbussche P; Deschuyteneer R; Wollmer A; Brailly H; Content J
Blood; 1997 Feb; 89(4):1319-33. PubMed ID: 9028955
[TBL] [Abstract][Full Text] [Related]
11. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
[TBL] [Abstract][Full Text] [Related]
12. The design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modeling.
Feng J; Li Y; Shen B
Peptides; 2004 Jul; 25(7):1123-31. PubMed ID: 15245871
[TBL] [Abstract][Full Text] [Related]
13. Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling.
Li H; Wang H; Nicholas J
J Virol; 2001 Apr; 75(7):3325-34. PubMed ID: 11238858
[TBL] [Abstract][Full Text] [Related]
14. Phage display as a rapid gene expression system: production of bioactive cytokine-phage and generation of neutralizing monoclonal antibodies.
Gram H; Strittmatter U; Lorenz M; Glück D; Zenke G
J Immunol Methods; 1993 May; 161(2):169-76. PubMed ID: 8505547
[TBL] [Abstract][Full Text] [Related]
15. Receptor recognition by gp130 cytokines.
Bravo J; Heath JK
EMBO J; 2000 Jun; 19(11):2399-411. PubMed ID: 10835339
[TBL] [Abstract][Full Text] [Related]
16. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
[TBL] [Abstract][Full Text] [Related]
17. Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiation.
Ehlers M; Grötzinger J; Fischer M; Bos HK; Brakenhoff JP; Rose-John S
J Interferon Cytokine Res; 1996 Aug; 16(8):569-76. PubMed ID: 8877726
[TBL] [Abstract][Full Text] [Related]
18. Structure of an extracellular gp130 cytokine receptor signaling complex.
Chow D; He X; Snow AL; Rose-John S; Garcia KC
Science; 2001 Mar; 291(5511):2150-5. PubMed ID: 11251120
[TBL] [Abstract][Full Text] [Related]
19. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.
Suthaus J; Adam N; Grötzinger J; Scheller J; Rose-John S
Eur J Cell Biol; 2011; 90(6-7):495-504. PubMed ID: 21176991
[TBL] [Abstract][Full Text] [Related]
20. Synthetic peptides mimicking the interleukin-6/gp130 interaction: a two-helix bundle system. Design and conformational studies.
Zaccaro L; Bucci E; Vitale RM; Perretta G; Fattorusso R; Benedetti E; Saviano M; Pedone C
J Pept Sci; 2003 Feb; 9(2):90-105. PubMed ID: 12630694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
